Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2).

Melanoma research - 1 Jun 1994

Scheibenbogen C, Keilholz U, Mytilineos J, Suciu S, Manasterski M, Hunstein W

Abstract excerpt

MHC-restricted recognition of melanoma cells by cytotoxic T lymphocytes is an important mechanism in vitro. Several HLA alleles can function as restriction elements for melanoma cell recognition. In this study we investigated whether there is a correlation between responsiveness of patients with metastatic melanoma (MM) to immunotherapy and the HLA type of the patient. Seventy-two patients received immunotherapy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Genes, MHC Class I

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Histocompatibility Antigens Class I

Share to HLA-B Antigens

Share to Interleukin-2

Share to Lymphocytes

Share to Melanoma

Share to Recombinant Proteins

Source

Identifiers

PMID: 7919965
DOI: 10.1097/00008390-199406000-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2).PMID 7919965Read ↗

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.Semantic proximity Read ↗

Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy.Semantic proximity Read ↗

Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.Semantic proximity Read ↗

HLA-B8 association with late-stage melanoma--an immunological lesson?Semantic proximity Read ↗

High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.Semantic proximity Read ↗

HLA-DQ1 is associated with clinical response and survival of patients with melanoma who are treated with interleukin-2.Semantic proximity Read ↗

Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviations.Semantic proximity Read ↗

Genetic evolution of T-cell resistance in the course of melanoma progression.Semantic proximity Read ↗

Unbalanced expression of HLA-A and -B antigens: a specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-gamma.Semantic proximity Read ↗

Immunotherapy: HLA-1 genotype influences response to checkpoint inhibitors.Semantic proximity Read ↗

Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients.Semantic proximity Read ↗

The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.